Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AZN | AMGN | GILD | BMY |
| Company | Apellis Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 20.53 | 94.47 | 328.70 | 123.80 | 56.46 |
| High | 20.70 | 94.68 | 333.03 | 125.12 | 56.56 |
| Low | 19.76 | 93.51 | 326.90 | 122.10 | 55.10 |
| Latest | 19.94 | 94.39 | 330.41 | 124.91 | 55.26 |
| Change | -0.59 | +0.40 | +0.38 | +3.65 | -1.36 |
| % Change | -2.87% | +0.43% | +0.12% | +3.01% | -2.40% |
| Volume | 2,257,600 | 55,050,699 | 4,033,800 | 10,639,000 | 13,702,800 |
| 20-Day Average Volume | 2,804,605 | 7,862,720 | 2,749,175 | 6,405,805 | 14,318,740 |
| Previous Close | 20.53 | 93.99 | 330.03 | 121.26 | 56.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.25 | 93.12 | 329.14 | 122.91 | 54.90 |
| 20-Day Raw Stochastic | 2.34% | 69.63% | 49.11% | 76.26% | 64.26% |
| 20-Day Relative Strength | 38.61 | 57.65 | 52.74 | 53.81 | 59.07 |
| Weighted Alpha | -18.71 | +44.41 | +22.07 | +32.21 | +6.63 |
| Today's Opinion | 24% Sell | 100% Buy | 64% Buy | 72% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -26.96% since 01/09/26 | -0.27% since 01/09/26 | +1.32% since 01/09/26 | +3.15% since 01/09/26 | -1.07% since 01/09/26 |
| Low | 19.76 on 01/16/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 55.10 on 01/16/26 |
| High | 26.55 on 01/12/26 | 96.43 on 01/14/26 | 333.03 on 01/16/26 | 125.12 on 01/16/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | -21.22% since 12/16/25 | +3.33% since 12/16/25 | +1.12% since 12/16/25 | +5.16% since 12/16/25 | +1.90% since 12/16/25 |
| Low | 19.76 on 01/16/26 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 27.46 on 01/09/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | -17.43% since 10/16/25 | +12.60% since 10/16/25 | +11.70% since 10/16/25 | +5.99% since 10/16/25 | +27.36% since 10/16/25 |
| Low | 18.75 on 11/07/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 30.48 on 10/28/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | +0.96% since 07/16/25 | +34.69% since 07/16/25 | +10.50% since 07/16/25 | +13.71% since 07/16/25 | +17.15% since 07/16/25 |
| Low | 18.48 on 07/29/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 30.48 on 10/28/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,522,909 | 292,780,416 | 177,919,520 | 154,973,344 | 112,495,712 |
| Shares Outstanding, K | 126,525 | 3,101,816 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 781,370,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -197,880,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 458,580,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | 215,720,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.31 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.67 on 10/30/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 02/27/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 66.23 | 20.57 | 15.09 | 14.81 | 8.63 |